Skip to main content
Experimental Hematology & Oncology logoLink to Experimental Hematology & Oncology
. 2024 Jan 23;13:7. doi: 10.1186/s40164-024-00472-z

Correction: Breast cancer heterogeneity and its implication in personalized precision therapy

Liantao Guo 1,#, Deguang Kong 1,#, Jianhua Liu 1, Ling Zhan 1, Lan Luo 3, Weijie Zheng 1, Qingyuan Zheng 2, Chuang Chen 1,, Shengrong Sun 1,
PMCID: PMC10807152  PMID: 38263215

Correction: Experimental Hematology & Oncology (2023) 12:3 10.1186/s40164-022-00363-1

In the Funding secion of this article [1], the grant number relating to National Natural Science Foundation of China was given incorrectly as No.8210114078 and should have been No.82103671.

Funding

This work was funded by the National Natural Science Foundation of China (Grant No.82103671).

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Liantao Guo and Deguang Kong contributed equally to this work.

Contributor Information

Chuang Chen, Email: chen0678@126.com.

Shengrong Sun, Email: sun137@sina.com.

Reference

  • 1.Guo L, Kong D, Liu J, Zhan L, Luo L, Zheng W, Zheng Q, Chen C, Sun S. Breast cancer heterogeneity and its implication in personalized precision therapy. Exp Hematol Oncol. 2023;12:3. doi: 10.1186/s40164-022-00363-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Experimental Hematology & Oncology are provided here courtesy of BMC

RESOURCES